From cholera to enterotoxigenic Escherichia coli (ETEC) vaccine development
2011

Development of Vaccines Against Cholera and ETEC

Sample size: 700 publication Evidence: moderate

Author Information

Author(s): Svennerholm Ann-Mari

Primary Institution: University of Gothenburg

Hypothesis

Protection against cholera and ETEC should target both bacterial colonization and toxin action.

Conclusion

The study demonstrates that oral inactivated vaccines can provide significant protection against cholera and ETEC diarrhoea.

Supporting Evidence

  • Oral vaccines provided 85-100% short-term protection against cholera.
  • Repeated oral immunizations were superior in eliciting immune responses.
  • Vaccines showed significant protection against non-mild ETEC diarrhoea in American travellers.

Takeaway

Scientists are working on vaccines to protect against two types of bacteria that cause diarrhea, and they found that giving the vaccine by mouth works best.

Methodology

The study used rabbit ileal loop techniques and human trials to evaluate vaccine efficacy.

Limitations

The vaccine showed lower efficacy in young children compared to adults.

Participant Demographics

Participants included adults and children from various countries, including Sweden, Bangladesh, and Egypt.

Statistical Information

P-Value

0.039

Statistical Significance

p=0.039

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication